Activest Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Activest Wealth Management's BMY Position: Q2 2026 in Review
Activest Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 36% in Q2 2026, selling an estimated $44K and leaving 1,389 shares worth $80K. The position accounts for 0.02% of the portfolio, ranked #209.
Activest Wealth Management first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $131K in Q1 2026. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Activest Wealth Management held 1,389 shares of Bristol-Myers Squibb worth $80K as of Q2 2026.
- Activest Wealth Management sold 767 Bristol-Myers Squibb shares in Q2 2026, an estimated $44K.
- Bristol-Myers Squibb made up 0.02% of Activest Wealth Management's portfolio in Q2 2026, its #209 holding.
- Activest Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Activest Wealth Management's Bristol-Myers Squibb position peaked at $131K in Q1 2026.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.